Sanofi's participation in the OTC market could end as early as next year with its plan to completely separate from its Consumer Healthcare business.
Sanofi is set to exit the OTC market by separating from its Consumer Healthcare business and completing a move almost four years in the making.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
A round-up of the latest European health & wellness market moves: Maxwellia names chief operating officer; Nestle appoints marketing & sales head; Alland & Robert gets deputy general manager.
European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.
Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.
Kemin Industries founder, human and animal health care innovator RW Nelson dies; Heather Remley moves from BASF’s Global Engineering to North America business helm; and golfer Bryson DeChambeau links up with Bucked Up.
European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.
